Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Cass

Showing results (261-270 of 289) with videos related to

Pageof 29
Sort By:
Diabetes Care|August 5, 2009
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trialSophia Zoungas, Bastiaan E de Galan, Toshiharu Ninomiya, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2009
Lowering blood pressure reduces renal events in type 2 diabetesBastiaan E de Galan, Vlado Perkovic, Toshiharu Ninomiya, et al.
Clinical Biochemistry|November 30, 2016
Comparison of creatinine and cystatin C based eGFR in the estimation of glomerular filtration rate in Indigenous Australians: The eGFR StudyElizabeth Lm Barr, Louise J Maple-Brown, Federica Barzi, et al.
Nephrology (Carlton, Vic.)|May 13, 2016
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialJoel Gummer, Robert Trengove, Elaine M Pascoe, et al.
European Journal of Preventive Cardiology|March 29, 2014
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease riskAnushka Patel, Alan Cass, David Peiris, et al.
Heart (British Cardiac Society)|January 18, 2020
Performance of cardiovascular risk prediction equations in Indigenous AustraliansElizabeth Laurel Mary Barr, Federica Barzi, Athira Rohit, et al.
The New England Journal of Medicine|November 14, 2017
Outcomes after Angiography with Sodium Bicarbonate and AcetylcysteineSteven D Weisbord, Martin Gallagher, Hani Jneid, et al.
BMC Health Services Research|July 15, 2026
Improving health workforce retention in remote Australia: a best-worst scaling studyNanda Kaji Budhathoki, John S Humphreys, Supriya Mathew, et al.
International Journal of Cardiology|January 7, 2016
Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countriesRuth Webster, Anushka Patel, Vanessa Selak, et al.
Journal of Clinical & Translational Endocrinology|December 9, 2020
Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected dataHongmei Zhang, Kris Rogers, Louisa Sukkar, et al.
Pageof 29

Showing results (261-270 of 289) with videos related to

Sort By:
Pageof 29
Diabetes Care|August 5, 2009
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trialSophia Zoungas, Bastiaan E de Galan, Toshiharu Ninomiya, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2009
Lowering blood pressure reduces renal events in type 2 diabetesBastiaan E de Galan, Vlado Perkovic, Toshiharu Ninomiya, et al.
Clinical Biochemistry|November 30, 2016
Comparison of creatinine and cystatin C based eGFR in the estimation of glomerular filtration rate in Indigenous Australians: The eGFR StudyElizabeth Lm Barr, Louise J Maple-Brown, Federica Barzi, et al.
Nephrology (Carlton, Vic.)|May 13, 2016
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialJoel Gummer, Robert Trengove, Elaine M Pascoe, et al.
European Journal of Preventive Cardiology|March 29, 2014
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease riskAnushka Patel, Alan Cass, David Peiris, et al.
Heart (British Cardiac Society)|January 18, 2020
Performance of cardiovascular risk prediction equations in Indigenous AustraliansElizabeth Laurel Mary Barr, Federica Barzi, Athira Rohit, et al.
The New England Journal of Medicine|November 14, 2017
Outcomes after Angiography with Sodium Bicarbonate and AcetylcysteineSteven D Weisbord, Martin Gallagher, Hani Jneid, et al.
BMC Health Services Research|July 15, 2026
Improving health workforce retention in remote Australia: a best-worst scaling studyNanda Kaji Budhathoki, John S Humphreys, Supriya Mathew, et al.
International Journal of Cardiology|January 7, 2016
Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countriesRuth Webster, Anushka Patel, Vanessa Selak, et al.
Journal of Clinical & Translational Endocrinology|December 9, 2020
Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected dataHongmei Zhang, Kris Rogers, Louisa Sukkar, et al.
Pageof 29